Drug Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Aptium Oncology

Future myeloma clinical trials will soon use the International Response Criteria

According to a study from the United States, "New uniform response criteria are required to adequately assess clinical outcomes in myeloma. The European Group for Blood and Bone Marrow Transplant/International Bone Marrow Transplant Registry criteria have been expanded, clarified and updated to provide a new comprehensive evaluation system."

"Categories for stringent complete response and very good partial response are added," explained B.G.M. Durie and colleagues, Aptium Oncology Inc. "The serum free light-chain assay is included to allow...

• View Other Issues of Drug Law Weekly
  
• View Other NewsRx Publications